HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gwendolyn Fate Selected Research

UK 453,061

4/2015Two-year carcinogenicity study in rats with a nonnucleoside reverse transcriptase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gwendolyn Fate Research Topics

Disease

1Adenocarcinoma
04/2015
1Adenoma (Adenomas)
04/2015
1Body Weight (Weight, Body)
04/2015
1Carcinoma (Carcinomatosis)
04/2015
1Transitional Cell Carcinoma
04/2015
1Hyperplasia
04/2015
1Hypertrophy
04/2015
1Neoplasms (Cancer)
04/2015
1Urinary Calculi (Urinary Calculus)
04/2015
1Liver Cell Adenoma (Hepatocellular Adenoma)
04/2015

Drug/Important Bio-Agent (IBA)

1UK 453,061IBA
04/2015
1EnzymesIBA
04/2015
1Reverse Transcriptase InhibitorsIBA
04/2015